Apoptosis and muscle fibre loss in neuromuscular disorders

Neuromuscular Disorders

Volumn 12, Issue 7-8, 2002, Pages 613-622

  Tews, D S ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Apoptosis; Muscle fibres; Neuromuscular disorders

Indexed keywords

ACETYLCYSTEINE; ADENOSINE; CASPASE; CASPASE INHIBITOR; DNA FRAGMENT; FLUPIRTINE; GELSOLIN; IDEBENONE; ISATIN DERIVATIVE; NITRIC OXIDE; OXYGEN RADICAL; PROTEIN BAX; PROTEIN BCL 2; RESVERATROL;

ANIMAL CELL; APOPTOSIS; CELL DEATH; CELL LOSS; CELL NUCLEUS; CYTOPATHOLOGY; ENZYME ACTIVATION; ENZYME INHIBITION; HOMEOSTASIS; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCULAR DYSTROPHY; MYOPATHY; NEUROMUSCULAR DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW;

ANIMALS; APOPTOSIS; ATROPHY; GENES, BCL-2; HUMANS; METABOLIC DISEASES; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOSITIS; NEUROMUSCULAR DISEASES; OXIDATIVE STRESS; UP-REGULATION;

EID: 0036788751     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00030-5     Document Type: Review

References (132)

1. Jacotot E., Costantini P., Laboureau E., Zamzami N., Susin S.A., Kroemer G. Mitochondrial membrane permeabilization during the apoptotic process. Ann N Y Acad Sci. 887:1999;18-30.
2. Chakraborti T., Das S., Mondal M., Roychoudhury S., Chakraborti S. Oxidant, mitochondria and calcium: an overview. Cell Signal. 11:1999;77-85.
3. Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cell. 3:1998;697-707.
4. Loeffler M., Kroemer G. The mitochondrion in cell death control: certainties and incognita. Exp Cell Res. 256:2000;19-26.
5. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 15:1999;269-290.
6. Slee E.A., Harte M.T., Kluck R.M., et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 144:1999;281-292.
7. Fidzianska A., Kaminska A., Glinka Z. Muscle cell death. Ultrastructural differences between muscle cell necrosis and apoptosis. Neuropathol Pol. 29:1991;19-28.
8. Fidzianska A. Apoptosis in human embryonic and diseased skeletal muscle. Basic Appl Myol. 6:1996;261-264.
9. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
10. Dawson B.A., Lough J. Immunocytochemical localization of transient DNA strand breaks in differentiating myotubes using in situ nick-translation. Dev Biol. 127:1988;362-367.
11. Denecker G., Vercammen D., Declercq W., Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci. 58:2001;356-370.
12. Lemasters J.J., Nieminen A.-L., Quin T., et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta. 1366:1998;177-196.
13. Daugas E., Susin S.A., Zamzami N., et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 14:2000;729-739.
14. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 92:1995;7162-7166.
15. Bal-Price A., Brown G.C. Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria. J Neurochem. 75:2000;1455-1464.
16. Reid M.B., Haack K.E., Franchek K.M., Valberg P.A., Kobzik L., West M.S. Reactive oxygen in skeletal muscle I. Intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol. 73:1992;1797-1804.
17. Reid M.B., Shoji T., Moody M.R., Entman M.L. Reactive oxygen in skeletal muscle II. Extracellular release of free radicals. J Appl Physiol. 73:1992;1805-1809.
18. Matsumoto A., Hirata Y., Momomura S., et al. Increased nitric oxide production during exercise. Lancet. 343:1994;849-850.
19. Li J., Billiar T.R. The role of nitric oxide in apoptosis. Semin Perinatol. 24:2000;46-50.
20. Brenman J.E., Chao D.S., Xia H., Aldape K., Bredt D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell. 82:1995;743-752.
21. Reid M. Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand. 162:1998;401-409.
22. Crow J.P., Beckman J.S. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr Top Microbiol Immunol. 196:1995;57-73.
23. Yang C.C., Alvarez R.B., Engel W.K., Askanas V. Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis. Neuroreport. 8:1996;153-158.
24. Yang C.C., Alvarez R.B., Engel W.K., Heller S.L., Askanas V. Nitric oxide-induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies. Brain. 121:1998;1089-1097.
25. Webb J.N. The development of human skeletal muscle with particular reference to muscle cell death. J Pathol. 123:1972;175-180.
26. Fidzianska A., Goebel H.H. Human ontogenesis III. Cell death in fetal muscle. Acta Neuropathol. 81:1991;572-579.
27. Sandri M., Carraro U. Apoptosis of skeletal muscles during development and disease. Int J Biochem Cell Biol. 31:1999;1373-1390.
28. Tews D.S., Goebel H.H. DNA-fragmentation and bcl-2 expression in infantile spinal muscular atrophy. Neuromuscul Disord. 6:1996;265-273.
29. Tews D.S., Goebel H.H. Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J Neuropathol Exp Neurol. 56:1997;150-156.
30. Tews D.S., Goebel H.H., Meinck H.M. DNA-fragmentation and apoptosis-related proteins of muscle cells in motor neuron disorders. Acta Neurol Scand. 96:1997;380-386.
31. Sandri M., Minetti C., Pedemonte M., Carraro U. Apoptotic myonuclei in human Duchenne muscular dystrophy. Lab Invest. 78:1998;1005-1016.
32. Sandri M., El Meslemani A.H., Sandri C., et al. Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment. J Neuropathol Exp Neurol. 60:2001;302-312.
33. Burgess D.H., Svensson M., Dandrea T., et al. Human skeletal muscle cytosols are refractory to cytochrome c-dependent activation of type-II caspases and lack APAF-1. Cell Death Differ. 6:1999;156-161.
34. Tews D.S., Goebel H.H. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies. Neuropathol Appl Neurobiol. 23:1997;331-338.
35. Yamada H., Nakagawa M., Higuchi I., Ohkubo R., Osame M. Type II muscle fibers are stained by anti-Fas antibody. J Neurol Sci. 134:1995;115-118.
36. Inukai A., Kobayashi Y., Ito K., et al. Expression of Fas antigen is not associated with apoptosis in human myopathies. Muscle Nerve. 20:1997;702-709.
37. Sugiura T., Murakawa Y., Nagai A., Kondo M., Kobayashi S. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis. Arthritis Rheum. 42:1999;291-298.
38. Yan C., Ikezoe K., Nonaka I. Apoptotic muscle fiber degeneration in distal myopathy with rimmed vacuoles. Acta Neuropathol. 101:2001;9-16.
39. Huppertz B., Tews D.S., Kaufmann P. Apoptosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int Rev Cytol. 205:2001;215-253.
40. Tews D.S., Goebel H.H., Schneider I., Gunkel A., Stennert E., Neiss W.F. DNA-fragmentation and expression of apoptosis-related proteins in experimentally denervated and reinnervated rat facial muscle. Neuropathol Appl Neurobiol. 23:1997;141-149.
41. Borisov A.B., Carlson B.M. Cell death in denervated skeletal muscle is distinct from classical apoptosis. Anat Rec. 258:2000;305-318.
42. Dupont-Versteegden E.E., Murphy R.J., Houle J.D., Gurley C.M., Peterson C.A. Activated satellite cells fail to restore myonuclear number in spinal cord transected and exercised rats. Am J Physiol. 277:1999;C589-C597.
43. Darr K.C., Schultz E. Exercise-induced satellite cell activation in growing and mature skeletal muscle. J Appl Physiol. 63:1987;1816-1821.
44. Rosenblatt J.D., Yong D., Parry D.J. Satellite cell activity is required for hypertrophy of overloaded adult rat muscle. Muscle Nerve. 17:1994;608-613.
45. Mukasa T., Momoi T., Momoi M.Y. Activation of caspase-3 apoptotic pathways in skeletal muscle fibers in laminin alpha2-deficient mice. Biochem Biophys Res Commun. 260:1999;139-142.
46. Ikezoe K., Yan C., Momoi T., et al. A novel congenital myopathy with apoptotic changes. Ann Neurol. 47:2000;531-536.
47. Di Giovanni S., Mirabella M., D'Amico A., Tonali P., Servidei S. Apoptotic features accompany acute quadriplegic myopathy. Neurology. 55:2000;854-858.
48. Libera L.D., Zennaro R., Sandri M., Ambrosio G.B., Vescovo G. Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am J Physiol. 277:1999;C982-C986.
49. Vescovo G., Volterrani M., Zennaro R., et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart. 84:2000;431-437.
50. Yasuhara S., Kanakubo E., Perez M.E., et al. The Moyer award. Burn injury induces skeletal muscle apoptosis and the activation of caspase pathways in rats. J Burn Care Rehabil. 20:1999;462-470.
51. Fidzianska A., Goebel H.H., Warlo I. Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. Brain. 113:1990;433-445.
52. Lockshin R.A., Zakeri Z. Apoptosis in the cytoplasm. Basic Appl Myol. 6:1996;209-214.
53. Hoffman E.P., Fischbeck K.H., Brown R.H., et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med. 318:1988;1363-1368.
54. Matsumura K., Tomé F.M., Collin H., et al. Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature. 359:1992;320-322.
55. Tomé F.M., Evangelista T., Leclerc A., et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci Paris. 317:1994;351-357.
56. Tidball J.G., Albrecht D.E., Lokensgard B.E., Spencer M.J. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci. 108:1995;2197-2204.
57. Sandri M., Carraro U., Podhorska-Okolov M., et al. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibres after exercise. FEBS Lett. 373:1995;291-295.
58. Sandri M., Podhorska-Okolov M., Geromel V., et al. Exercise induces myonuclear ubiquitination and apoptosis in dystrophin deficient muscle of mice. J Neuropathol Exp Neurol. 56:1997;45-57.
59. Vachon P.H., Loechel F., Xu H., Wewer U., Engvall E. Merosin and laminin in myogenesis: specific requirement for merosin in myotube stability and survival. J Cell Biol. 134:1996;1483-1497.
60. Vachon P.H., Xu H., Liu L., et al. Intergrins (α7β1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest. 100:1997;1870-1881.
61. Miyagoe Y., Hanaoka K., Nonaka I., et al. Laminin alpha 2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett. 415:1997;33-39.
62. Hack A.A., Ly C.T., Jiang F., et al. Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol. 142:1998;1279-1287.
63. Baghdiguian S., Martin M., Richard I., et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med. 5:1999;503-511.
64. Behrens L., Bender A., Johnson M.A., Hohlfeld R. Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells. Brain. 120:1997;929-938.
65. Migheli A., Mongini T., Doriguzzi C., et al. Muscle apoptosis in human occurs in normal and denervated muscle, but not in myotonic dystrophy, dystrophinopathies or inflammatory disease. Neurogenetics. 1:1997;81-87.
66. Olive M., Martinez-Matos J.A., Montero J., Ferrer I. Apoptosis is not the mechanism of cell death of muscle fibers in human muscular dystrophies and inflammatory myopathies. Muscle Nerve. 20:1997;1328-1330.
67. Richter C. On the role of energy decline in muscle cell apoptosis. Basic Appl Myol. 6:1996;215-219.
68. Leist M., Single B., Naumann H., et al. Inhibition of ATP generation by nitric oxide switches apoptosis to necrosis. Exp Cell Res. 249:1999;396-403.
69. Nicotera P., Leist M., Fava E., Berliocchi L., Volbracht C. Energy requirements for caspase activation and neuronal cell death. Brain Pathol. 10:2000;276-282.
70. Carraro U. Apoptotic death of dystrophic muscle fibres after exercise: a new hypothesis on the early events of muscle damage. Basic Appl Myol. 5:1995;371-374.
71. Podhorska-Okolow M., Sandri M., Bruson A., et al. Apoptotic myonuclei appear in adult skeletal muscle of normal and mdx mice after a mild exercise. Basic Appl Myol. 5:1995;87-90.
72. McArdle A., Edwards R.H.T., Jackson M.J. How does dystrophin deficiency lead to muscle degeneration? Evidence from the mdx mouse. Neuromuscul Disord. 5:1995;445-446.
73. Rath P.C., Aggarwal B.B. TNF-induced signaling in apoptosis. J Clin Immunol. 19:1999;350-364.
74. Lemasters J.J., Qian T., Bradham C.A., et al. Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J Bioenerg Biomembr. 31:1999;305-319.
75. Kroemer G., Reed J.C. Mitochondrial control of death. Nat Med. 6:2000;513-519.
76. Spencer M.J., Croall D.E., Tidball J.G. Calpains are activated in necrotic fibres from mdx dystrophic mice. J Biol Chem. 270:1995;10909-10914.
77. Tews D.S., Goebel H.H. Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol. 55:1996;342-347.
78. Higushi M., Proske R.J., Yeh E.T. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene. 17:1998;2515-2524.
79. Formigli L., Papucci L., Tani A., et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol. 182:2000;41-49.
80. Olive M., Ferrer I. Bcl-2 and bax protein expression in human myopathies. J Neurol Sci. 164:1999;76-81.
81. Coulton G.R., Rogers B., Strutt P., Skynner M.J., Watt D.J. In situ localization of single-stranded DNA breaks in nuclei of a subpopulation of cells within regenerating skeletal muscle of the dystrophic mdx mouse. J Cell Sci. 102:1992;653-662.
82. McArdle A., Maglara A., Appleton P., Watson A.J., Grierson I., Jackson M.J. Apoptosis in multinucleated skeletal muscle myotubes. Lab Invest. 79:1999;1069-1076.
83. Iwakura T., Fujimoto S., Kagimoto S., et al. Sustained enhancement of Ca(2+) influx by glibenclamide induces apoptosis in RINm5F cells. Biochem Biophys Res Commun. 271:2000;422-428.
84. Haycock J.W., MacNeil S., Jones P., Harris J.B., Mantle D. Oxidative damage to muscle protein in Duchenne muscular dystrophy. Neuroreport. 8:1996;357-361.
85. 2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. J Neuropathol Exp Neurol. 55:1996;36-43.
86. Ragusa R.J., Chow C.K., Porter J.D. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul Disord. 7:1997;376-386.
87. Disatnik M.H., Dhawan J., Yu Y., et al. Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J Neurol Sci. 26:1998;77-84.
88. Gossrau R., Grozdanovic Z., Christova T., Blottner D. Adhalin (α-sarcoglycan) is not required for anchoring of nitric oxide synthase I (NOS I) to the sarcolemma in non-mammalian skeletal (striated) muscle fibers. Acta Histochem. 98:1996;345-355.
89. Crosbie R.H., Straub V., Yun H.Y., et al. Mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet. 7:1998;823-829.
90. Grozdanovic Z., Baumgarten H.G. Nitric oxide synthase in skeletal muscle fibers: a signaling component of the dystrophin-glycoprotein complex. Histol Histopathol. 14:1999;243-256.
91. Sander M., Chavoshan B., Shannon A.H., et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci USA. 97:2000;13818-13823.
92. Monici M.C., Toscano A., Girlanda P., Aguennouz M., Musumeci O., Vita G. Apoptosis in metabolic myopathies. Neuroreport. 9:1998;2431-2435.
93. Mirabella M., Di Giovanni S., Silvestri G., Tonali P., Servidei s. Apoptosis in mitochondrial encephalopathies with mitochondrial DNA mutations: a potential pathogenic mechanism. Brain. 123:2000;93-104.
94. DiMauro S., Bonilla E., Davidson M., Hirano M., Schon E.A. Mitochondria in neuromuscular disorders. Biochim Biophys Acta. 1366:1998;199-210.
95. Schneider C., Gold R., Dalakas M.C., et al. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol. 55:1996;1205-1209.
96. Hohlfeld R., Engel A.G., Goebels N., Behrens L. Cellular immune mechanisms in inflammatory myopathies. Curr Opin Rheumatol. 9:1997;520-526.
97. Hutchinson D.O. Inclusion body myositis: abnormal protein accumulation does not trigger apoptosis. Neurology. 51:1998;1742-1745.
98. Tews D.S., Goebel H.H. Cell death and oxidative damage in inflammatory myopathies. Clin Immunol Immunopathol. 87:1998;240-247.
99. Nagaraju K., Casciola-Rosen L., Rosen A., et al. The inhibition of apoptosis in myositis and in normal muscle cells. J Immunol. 164:2000;5459-5465.
100. Adler S., Zettl H., Brück W., Zimmermann R., Zettl U.K. The role of apoptotic cell death and bcl-2 protein expression in dermatomyositis. Eur J Dermatol. 7:1997;413-416.
101. Fyhr I.M., Oldfors A. Upregulation of Fas/Fas ligand in inclusion body myositis. Ann Neurol. 43:1998;127-130.
102. Li M., Dalakas M.C. Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies. J Neuroimmunol. 106:2000;1-5.
103. Williams G., Brown T., Becker L., Prager M., Giroir B.P. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am J Physiol. 267:1994;R1020-R1025.
104. Beckman J.S., Chen J., Crow J.P., Ye Y.Z. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res. 103:1994;371-380.
105. Mangan D.F., Wahl S.M. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol. 147:1991;3408-3412.
106. Mulligan M.S., Hevel J.M., Marletta W.A., Ward P.A. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA. 88:1991;6338-6342.
107. Rubanyi G.M., Ho E.H., Cantor E.H., Lumma W.C., Botelho L.H. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun. 181:1991;1392-1397.
108. Akimitsu T., Gute D.C., Korthuis R.J. Leukocyte adhesion induced by inhibition of nitric oxide production in skeletal muscle. J Appl Physiol. 78:1995;1725-1732.
109. Sarih M., Souvannavong V., Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun. 191:1993;503-508.
110. Tidball J.G., St.Pierre B.A. Apoptosis of macrophages during the resolution of muscle inflammation. J Leukoc Biol. 59:1996;380-388.
111. Kobzik L., Reid M.B., Bredt D.S., Stammler J.S. Nitric oxide in skeletal muscle. Nature. 372:1994;546-548.
112. Cleeter M.W., Cooper J.M., Darley-Usmar V.M., Moncada S., Schapira A.H. Reversible inhibition of cytochrome C oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 345:1994;50-54.
113. Schmalbruch H. Natural killer cells and macrophages in immature denervated rat muscle. J Neuropathol Exp Neurol. 55:1996;310-319.
114. Broccolini A., Engel W.K., Askanas V. Localization of survival motor neuron protein in human apoptotic-like and regenerating muscle fibres, and neuromuscular junctions. Neuroreport. 10:1999;1637-1641.
115. Lefebvre S., Burglen L., Reboullet S., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 80:1995;155-165.
116. Roy N., Mahadevan M.S., McLean M., et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80:1995;167-178.
117. Gennarelli M., Lucarelli M., Capon F., et al. Survival motor neuron gene transcript analysis in muscle from spinal muscular atrophy patients. Biochem Biophys Res Commun. 213:1995;342-348.
118. Asayama K., Dettbarn W.D., Burr I.M. Differential effect of denervation on free-radical scavenging enzymes in slow and fast muscle of rat. J Neurochem. 46:1986;604-609.
119. Ninfali P., Cuppini C., Marinoni S. Effects of denervation on antioxidant enzymes in nerve and muscle of rats. Boll Soc Ital Biol Sper. 71:1995;1-6.
120. Kusner L.L., Kaminski H.J. Nitric oxide synthase is concentrated at the skeletal muscle endplate. Brain Res. 730:1996;238-242.
121. Tews D.S., Goebel H.H., Schneider I., Gunkel A., Stennert E., Neiss W.F. Expression of different isoforms of nitric oxide synthase in experimentally denervated and reinnervated rat facial muscle. J Neuropathol Exp Neurol. 56:1997;1283-1289.
122. Yamada H., Nakagawa M., Higuchi I., Horikiri T., Osame M. Detection of DNA fragmentation of myonuclei in myotonic dystrophy by double staining with anti-emerin antibody and by nick end-labeling. J Neurol Sci. 173:2000;97-102.
123. Amato A.A., Jackson C.E., Lampkin S., Kagan-Hallet K. Myofibrillar myopathy: no evidence of apoptosis by TUNEL. Neurology. 52:1999;861-863.
124. Koga M., Hiromatsu Y., Jimi A., Inoue Y., Nonaka K. Possible involvement of Fas-mediated apoptosis in eye muscle tissue from patients with thyroid-associated ophthalmopathy. Thyroid. 8:1998;311-318.
125. Brunelli G.A., Vigasio A., Brunelli G.R. Different conduits in peripheral nerve surgery. Microsurgery. 15:1994;176-178.
126. Susin S.A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta. 1366:1998;151-165.
127. Deigner H.P., Haberkorn U., Kinscherf R. Apoptosis modulators in the therapy of neurodegenerative diseases. Expert Opin Investig Drugs. 9:2000;747-764.
128. Zhao Z.Q., Budde J.M., Morris C., et al. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax protein. J Mol Cell Cardiol. 33:2001;57-68.
129. Kusano H., Shimizu S., Koya ?., et al. Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene. 19:2000;4807-4814.
130. Nuttall M.E., Lee D., McLaughlin B., Erhardt J.A. Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies. Drug Discov Today. 6:2001;85-91.
131. Rabuffetti M., Sciorati C., Tarozzo G., Clementi E., Manfredi A.A., Beltramo M. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J Neurosci. 20:2000;4398-4404.
132. Nicolini G., Rigolio R., Miloso M., Bertelli A.A., Tredici G. Anti-apoptotic effect of trans-resveratrol on paclitraxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line. Neurosci Lett. 302:2001;41-44.